This is a demo store. No orders will be fulfilled.

Polatuzumab (anti-CD79b) - Primary antibody, specific to CD79B, >95% (SDS-PAGE&SEC), high purity, Human IgG1

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Cynomolgus monkey,Human,Mouse
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab175715
Grouped product items
SKU Size
Availability
Price Qty
Ab175715-100μg
100μg
10
$59.90
Ab175715-1mg
1mg
4
$267.90
Ab175715-5mg
5mg
1
$687.90
Ab175715-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,077.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level< 0.01EU/μg ; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Polatuzumab (anti-CD79b) - Primary antibody, specific to CD79B, >95% (SDS-PAGE&SEC), high purity, Human IgG1
Synonyms AGM6 antibody | B cell antigen receptor complex associated protein beta chain antibody | B cell specific glycoprotein B29 antibody | B-cell antigen receptor complex-associated protein beta chain antibody | B-cell-specific glycoprotein B29 antibody | B29 a
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity CD79B
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Recombinant, Validated
Product Description

Polatuzumab (anti-CD79b) is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab (anti-CD79b) sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab (anti-CD79b) can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b.
Purity>95% (SDS-PAGE&SEC)
Endotoxin Level< 0.01EU/μg

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 27.4 kDa (Light Chain) & 51.8 kDa (Heavy Chain), under reducing conditions; 180.0 kDa, under non-reducing conditions.
Purification Method Protein A purified
Purity >95% (SDS-PAGE&SEC)
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2279068-37-8

Associated Targets(Human)

CD79B Tclin B-cell antigen receptor complex-associated protein beta chain (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Polatuzumab (anti-CD79b) (Ab175715) - ELISA
Immobilized hu-CD79b-His at 2 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC₅₀ of 4.09 ng/mL.

Polatuzumab (anti-CD79b) (Ab175715) - SEC
The purity of Polatuzumab (anti-CD79b) (Ab175715) is more than 95% verified by HPLC.

Recombinant Human CD79B Protein (rp176729) - ELISA
Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC50 of 11.08 ng/mL.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0303075 Certificate of Analysis Mar 08, 2024 Ab175715
ZJ24F0303074 Certificate of Analysis Mar 08, 2024 Ab175715
ZJ24F0303073 Certificate of Analysis Mar 08, 2024 Ab175715

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.